Casar-Borota O - Search Results

1

Expression of SSTR2a, but not of SSTRs 1, 3, or 5 in somatotroph adenomas assessed by monoclonal antibodies was reduced by octreotide and correlated with the acute and long-term effects of octreotide.

Casar-Borota O, Heck A, Schulz S, Nesland JM, Ramm-Pettersen J, Lekva T, Alafuzoff I, Bollerslev J. Casar-Borota O, et al. J Clin Endocrinol Metab. 2013 Nov;98(11):E1730-9. doi: 10.1210/jc.2013-2145. Epub 2013 Oct 3. J Clin Endocrinol Metab. 2013. PMID: 24092823 Clinical Trial.

2

Reduced levels of E-cadherin correlate with progression of corticotroph pituitary tumours.

Evang JA, Berg JP, Casar-Borota O, Lekva T, Kringen MK, Ramm-Pettersen J, Bollerslev J. Evang JA, et al. Clin Endocrinol (Oxf). 2011 Dec;75(6):811-8. doi: 10.1111/j.1365-2265.2011.04109.x. Clin Endocrinol (Oxf). 2011. PMID: 21595730

3

Adenoma granulation pattern correlates with clinical variables and effect of somatostatin analogue treatment in a large series of patients with acromegaly.

Fougner SL, Casar-Borota O, Heck A, Berg JP, Bollerslev J. Fougner SL, et al. Clin Endocrinol (Oxf). 2012 Jan;76(1):96-102. doi: 10.1111/j.1365-2265.2011.04163.x. Clin Endocrinol (Oxf). 2012. PMID: 21722151

4

Intensity of pituitary adenoma on T2-weighted magnetic resonance imaging predicts the response to octreotide treatment in newly diagnosed acromegaly.

Heck A, Ringstad G, Fougner SL, Casar-Borota O, Nome T, Ramm-Pettersen J, Bollerslev J. Heck A, et al. Clin Endocrinol (Oxf). 2012 Jul;77(1):72-8. doi: 10.1111/j.1365-2265.2011.04286.x. Clin Endocrinol (Oxf). 2012. PMID: 22066905

5

KIT protein expression and mutational status of KIT gene in pituitary adenomas.

Casar-Borota O, Fougner SL, Bollerslev J, Nesland JM. Casar-Borota O, et al. Virchows Arch. 2012 Feb;460(2):171-81. doi: 10.1007/s00428-011-1185-8. Epub 2012 Jan 3. Virchows Arch. 2012. PMID: 22213031

6

Different levels of various glucocorticoid-regulated genes in corticotroph adenomas.

Evang JA, Bollerslev J, Casar-Borota O, Lekva T, Ramm-Pettersen J, Berg JP. Evang JA, et al. Endocrine. 2013 Aug;44(1):220-7. doi: 10.1007/s12020-012-9871-0. Epub 2013 Jan 13. Endocrine. 2013. PMID: 23315031

7

Epithelial splicing regulator protein 1 and alternative splicing in somatotroph adenomas.

Lekva T, Berg JP, Lyle R, Heck A, Ringstad G, Olstad OK, Michelsen AE, Casar-Borota O, Bollerslev J, Ueland T. Lekva T, et al. Endocrinology. 2013 Sep;154(9):3331-43. doi: 10.1210/en.2013-1051. Epub 2013 Jul 3. Endocrinology. 2013. PMID: 23825128

8

Quantitative analyses of T2-weighted MRI as a potential marker for response to somatostatin analogs in newly diagnosed acromegaly.

Heck A, Emblem KE, Casar-Borota O, Bollerslev J, Ringstad G. Heck A, et al. Endocrine. 2016 May;52(2):333-43. doi: 10.1007/s12020-015-0766-8. Epub 2015 Oct 16. Endocrine. 2016. PMID: 26475495

9

Oncogene-Induced Senescence in Pituitary Adenomas--an Immunohistochemical Study.

Manojlovic-Gacic E, Skender-Gazibara M, Popovic V, Soldatovic I, Boricic N, Raicevic S, Pekic S, Doknic M, Miljic D, Alafuzoff I, Pontén F, Casar-Borota O. Manojlovic-Gacic E, et al. Endocr Pathol. 2016 Mar;27(1):1-11. doi: 10.1007/s12022-015-9405-4. Endocr Pathol. 2016. PMID: 26573928

10

MRI T2 characteristics in somatotroph adenomas following somatostatin analog treatment in acromegaly.

Heck A, Emblem KE, Casar-Borota O, Ringstad G, Bollerslev J. Heck A, et al. Endocrine. 2016 Jul;53(1):327-30. doi: 10.1007/s12020-015-0816-2. Epub 2015 Nov 28. Endocrine. 2016. PMID: 26615593 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

55 results

Search Page

Filters